A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth
by on Friday, August 10th, 2012 | No Comments
Condition: Breast Neoplasms
Intervention: Drug: Irosustat
Sponsors: Imperial College London; Imperial College London; Imperial Comprehensive Biomedical Research Centre; Ipsen; Imperial College Healthcare NHS Trust; Guy’s and St Thomas’ NHS Foundation Trust; University of Southern California; QPS Netherlands B.V.
Not yet recruiting – verified August 2012